Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lithium and Riluzole in ALS
NCT00818389Phase 3Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2009
- Primary completion
- Oct 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 3 trial of lithium carbonate in amyotrophic lateral sclerosis (ALS), sponsored by Massachusetts General Hospital. Started Jan 2009; status: terminated.
02
Drugs
lithium carbonate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00818389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00818389.